Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease

Conditions: Crohn Disease; Ulcerative Colitis Interventions: Drug: Adalimumab-680LT; Other: Control Sponsors: University Medical Center Groningen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials